Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 11 September 2025
      Prevention, early detection and intervention: how the EU Cardiovascular Health Plan could transform health in Europe
 
 
Read more here.
 

1 in 3 deaths in the EU are due to cardiovascular disease (CVD), with 20% of all premature deaths (before the age of 65) caused by cardiovascular conditions. In addition to the human suffering, cardiovascular disease is estimated to cost the European economy EUR282 billion each year. Prevention, early detection, timely intervention and long-term, person-centred management are essential for improving health outcomes and quality of life for patients, as well as underpinning much needed economic prosperity for Europe. 

To support the development of a robust EU CVH Plan, EFPIA and Vaccines Europe have published a position paper setting out detailed proposals for better cardiovascular health. It focuses on key goals in CVH and proposes concrete supportive actions required to turn aspiration into reality.  

Read more →
 
 
      News
 
  10 September 2025 EFPIA response to European Commission President State of the Union speech

The State of the Union speech highlights a number of positive and welcome initiatives from the European Commission over...

Read more →
 
 
 
      EFPIA Webinar - Decentralised clinical trials: Turning experience into established practice

 

The EFPIA Webinar Decentralised clinical trials: Turning experience into established practice explored what it takes to successfully adopt decentralised trial elements. From real-world insights at the clinical site level to high-level policy and patient perspectives, this session showed the opportunities, challenges, and systemic changes needed to scale innovation in clinical research.

Watch the recording here

 

 
 
      Events
 
 
22 SEP 2025
  EFPIA Life Sciences Week Brussels

A series of high-level policy discussions on the future of healthcare and innovation in Europe.

Learn more →
 
 
 
01 OCT 2025
  How to fight blood cancers with CAR-T cells and big data Online

Join us online on 1 October at 10:30 for a deep dive into four IHI projects that are revolutionising the fight against...

Learn more →
 
 
 
01 OCT 2025
  POLITICO Competitive Europe Summit Brussels, Belgium

Competitiveness isn’t just a regional concern—it is a race to be ahead in the global pecking order. With China and the...

Learn more →
 
 
 
04 NOV 2025
  IHI Brokerage Event 2025 Brussels, Belgium

If you’re interested in future IHI funding opportunities, the IHI Brokerage Event is the ideal place to network and...

Learn more →
 
 
      What we are reading
Denmark close to wiping out leading cancer-causing HPV strains after vaccine roll-out 02 September 2025  (Gavi) Read more →
Scientists are discovering a powerful new way to prevent cancer 02 September 2025  (The Economist) Read more →
The essential role of vaccines in healthy ageing 25 August 2025  (Vaccines Today) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe